Lenzing's 120 Million Euro Cost Drive Meets a 130 Million Euro Net Loss

Lenzing has given shareholders two very different things to weigh. On one side sits a cost programme designed to underwrite its restructuring; on the other, a bottom line that shows what that restructuring is costing in the here and now. The pre-market gain of 2.9% suggests the market has chosen to focus on the first. A closer read of the nine-month figures argues for keeping both in view.

Margins Move in the Right Direction

Revenue for the first nine months of 2026 came in at EUR 1.93 billion, down from EUR 1.97 billion a year earlier. Adjusted EBITDA held at EUR 353 million, essentially matching the prior-year level. The precise revenue figure was EUR 1,926.3 million.

That combination deserves credit rather than a shrug. Falling sales with a flat operating result implies the remaining revenue is being converted more efficiently. The adjusted EBITDA margin climbed to 18.3% from 17.9% over the nine-month stretch.

The third quarter sharpens the picture. At 17.3%, the quarterly adjusted EBITDA margin stood 4.0 percentage points higher than in the same period of 2025 — a gap too wide to dismiss as noise. What it does not do is prove that growth has returned. For that, investors would need to see revenue find its footing again, not just costs coming down.

The Bill Behind the Improvement

Restructuring charges of EUR 36.6 million pulled reported EBITDA down to EUR 316.4 million. Non-cash impairments of EUR 136.1 million on the Heiligenkreuz and Grimsby sites added further weight.

Should investors sell immediately? Or is it worth buying Lenzing?

The gap between adjusted and reported figures is where the story of the turnaround actually lives. The adjusted numbers strip out the cost of getting smaller. The reported numbers show the accounting price of that decision. Neither is wrong; they simply answer different questions.

The net result was a loss of EUR 130.3 million, compared with EUR 105 million a year earlier. Management is guiding toward adjusted EBITDA of EUR 430–460 million for the full year 2026.

A Leaner Footprint, a Longer To-Do List

The savings target is EUR 120 million in additional costs by the end of 2027, measured against the 2025 cost base — a commitment the company reaffirmed today. Roughly 600 jobs will go as part of the programme. Production at Heiligenkreuz is scheduled to cease by the end of the first quarter of 2027, with Grimsby set to follow by the end of that year.

Beyond cost-cutting, Lenzing intends to expand its nonwovens business and shift textile fibres toward premium and specialty products, retreating from low-margin standard fibres. That pivot is the strategic core of the plan, and it is also why the savings alone cannot be read as proof of a completed overhaul.

Medium-term ambitions are set out plainly: an EBITDA increase of EUR 150 million, an EBITDA margin of 20–25%, and a leverage ratio below 2.5. These are targets, not results. How quickly they show up in day-to-day operations and in cash generation is the open question.

Heiligenkreuz Still Awaits Its Verdict

The future of the Heiligenkreuz plant remains unresolved, and better margins do nothing to settle it. According to media reports, a field of roughly 30 interested buyers is to be narrowed in mid-November, with clarity on whether a new owner will keep the site running expected by the end of the year.

Lenzing at a turning point? This analysis reveals what investors need to know now.

Interest is not the same as a signed deal. Nor is a sale the same as continued operation. Treating either outcome as already achieved would be jumping ahead of the process — and the operating improvements in the rest of the business deserve to be judged on their own merits rather than upgraded by a hoped-for result in Heiligenkreuz.

Funding Is Banked, Cash Flow Is Not

The capital increase that took effect roughly two weeks ago brought in about EUR 300 million. A further EUR 300 million in financing arrangements is planned, with around half of that already agreed on a binding basis. The distinction between signed commitments and intentions matters here.

Net financial debt stood at EUR 1,418.9 million at the end of the reporting period. Free cash flow reached EUR 24.7 million, down sharply from EUR 110.9 million a year earlier.

That cash flow gap is the number to watch. Higher adjusted margins and a reinforced balance sheet are welcome, but the restructuring only proves itself when the savings land and the stabilised operations start producing stronger free cash. Until then, the improved earnings quality is the solid part of the story — and the growth question is the next test.

Ad

Lenzing Stock: New Analysis - 5 November

Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Lenzing analysis...